The specific and selective proteolysis of cardiac troponin I (cTnI) has been proposed to play a key role in human ischemic myocardial disease, including stunning and acute pressure overload. In this study, the functional implications of cTnI proteolysis were investigated in human cardiac tissue for the first time. The predominant human cTnI degradation product (cTnI ) and full-length cTnI were expressed in Escherichia coli, purified, reconstituted with the other cardiac troponin subunits, troponin T and C, and subsequently exchanged into human cardiac myofibrils and permeabilized cardiomyocytes isolated from healthy donor hearts. Maximal isometric force and kinetic parameters were measured in myofibrils, using rapid solution switching, whereas force development was measured in single cardiomyocytes at various calcium concentrations, at sarcomere lengths of 1.9 and 2.2 m, and after treatment with the catalytic subunit of protein kinase A (PKA) to mimic ␤-adrenergic stimulation. One-dimensional gel electrophoresis, Western immunoblotting, and 3D imaging revealed that approximately 50% of endogenous cTnI had been homogeneously replaced by cTnI in both myofibrils and cardiomyocytes. Maximal tension was not affected, whereas the rates of force activation and redevelopment as well as relaxation kinetics were slowed down. Ca 2ϩ sensitivity of the contractile apparatus was increased in preparations containing cTnI 1-192 (pCa 50 : 5.73Ϯ0.03 versus 5.52Ϯ0.03 for cTnI and full-length cTnI, respectively). The sarcomere length dependency of force development and the desensitizing effect of PKA were preserved in cTnI 1-192 -exchanged cardiomyocytes. These results indicate that degradation of cTnI in human myocardium may impair diastolic function, whereas systolic function is largely preserved.
I schemic myocardial disease is manifested in a mild form of reversible contractile dysfunction and a very serious, irreversible form (necrosis). The latter may be prevented only by timely restoration of coronary perfusion, but, even then, reversible contractile dysfunction is frequently apparent. The specific and selective proteolysis of the myofilament protein cardiac troponin I (cTnI) has been proposed to play a key role in human myocardial ischemia/reperfusion injury, including stunning [1] [2] [3] and in acute pressure overload. 4 cTnI is part of the cardiac troponin (cTn) complex that, in concert with tropomyosin (TM), regulates muscle contraction in response to a rise in intracellular Ca 2ϩ . The troponin complex consists of 3 subunits: troponin C (cTnC), the Ca 2ϩ binding protein; cTnI, which inhibits the actin/myosin interaction; and troponin T (cTnT), which transduces the Ca 2ϩ binding signal to TM. On Ca 2ϩ binding to the regulatory site of cTnC, the C-terminal regulatory segment of cTnI (residues 137 to 210) moves away from the actin filament, 5, 6 thereby altering the orientation and/or flexibility of cTn and TM relative to the actin filament. 5 Hence, cTnI plays a pivotal role in activation of cardiac myofilaments, and truncation of the cTnI C terminus, as observed in human ischemic cardiac disease, might alter the Ca 2ϩ -induced force development as well as the inhibition of force development at low Ca 2ϩ concentrations.
In rodents, McDonough et al 7 showed that with moderate ischemia/reperfusion, cTnI is cleaved at its C terminus, resulting in a degraded subunit cTnI . Ischemia-induced cTnI degradation has been proposed to be attributable to activation of the Ca 2ϩ -dependent proteolytic enzyme calpain-1 during Ca 2ϩ overload that occurs during reperfusion. 8 Increased preload in the absence of ischemia has also been shown to induce cTnI degradation. 4 In larger mammalian models, such as a postinfarct pig 9 and dog 10 model, minor degradation of cTnI (Ͻ4%) was observed in the viable remodeled left ventricle. Whereas in the dog, cTnI degradation did not correlate with the in vivo cardiac dysfunction in the whole heart, 10 in the pig, the maximal force generating capacity of the individual myofilaments was reduced compared with myocardium of sham-operated animals. 9 In advanced human heart failure, serum cTnI elevations have been reported. 11 In addition, cTnI degradation has been found in human cardiac tissue from coronary artery disease patients with different degrees of heart failure and a history of myocardial infarction. [1] [2] [3] The primary cTnI degradation product found in these hearts was identified as cTnI (equivalent to cTnI in rodent myocardium 7 ) . Hence, also in humans, C-terminal truncation of cTnI may underlie impaired cardiac function in ischemia-induced cardiomyopathy and heart failure. However, the direct effects of cTnI proteolysis on contractile function of human cardiac myofilaments and isolated cardiac myocytes have not been investigated.
The contractile apparatus responds quickly to increases in hemodynamic load (via the Frank-Starling mechanism) and to ␤-adrenergic stimulation, resulting in an increase and decrease in myofilament Ca 2ϩ sensitivity, respectively. In failing hearts, both processes are blunted. Evidence suggests 12,13 that cTnI plays an important role in these regulatory processes, by modulating length-dependent activation and by its phosphorylation through protein kinase A (PKA) of Ser23/24 in the N terminus. 6 For instance, it has been shown 14 that transduction of the PKA-induced phosphorylation signal from cTnI to the regulatory site of cTnC involves a global change in cTnI structure. Hence it is of interest to study whether or not the changes in Ca 2ϩ sensitivity associated with the Frank-Starling mechanism and ␤-adrenergic stimulation are perturbed by C-terminal truncation of cTnI in human isolated myocytes and myofibrils.
In this study, protein engineering was combined with functional measurements to assess the direct effects of degradation of the cTnI C terminus in human myocardium. Force measurements were performed in human cardiac myofibrils and cardiomyocytes, in which endogenous troponin complexes were partly replaced by complexes, denoted by cTn FL and cTn , containing human full-length cTnI or truncated cTnI , respectively. The advantage of this technique is that it allows to investigate the direct effect of cTnI degradation on contractility of human cardiac preparations without degradation of other contractile proteins (as eg, follows calpain-1 treatment) 15, 16 or other compensatory protein changes, which may develop in transgenic animals.
Force development at maximal and submaximal [Ca 2ϩ ] and kinetic parameters of force activation and relaxation in preparations containing cTn were compared with those containing cTn FL . In the presence of cTn , maximal isometric force, length-dependent activation and the effect of PKA were preserved, whereas Ca 2ϩ sensitivity was increased and the kinetics of activation and relaxation of human cardiac preparations were slowed. These results indicate that C-terminal truncation of cTnI mainly impairs diastolic properties of human myocardium, whereas the maximum force generating capacity, the Frank-Starling effect and the ␤-adrenergic responsiveness are preserved.
Materials and Methods
An expanded Materials and Methods section can be found in the online data supplement, available at http://circres.ahajournals.org.
Preparation of Recombinant Troponin Complexes
The human cardiac full-length cTnI and truncated cTnI (cTnI ) were prepared as described previously. 17
Isolation of Human Myofibrils and Cardiomyocytes
Left ventricular tissue was obtained from healthy donor hearts (nϭ4). Samples were obtained with approval of the local ethical committees and after informed written consent. Single myofibrils, bundles of a few myofibrils or single cardiac myocytes were prepared from these biopsies, as described previously. 18, 19 
Exchange of Human Cardiac Troponin Complex
Exchange of human cTn complex into human myofibrils and myocytes was performed according previously published methods. 18, 20 Evaluation of both cTn FL and cTn exchange into human cardiac preparations was based on the amount of cTnI exchange.
Force Measurements in Exchanged Human Myofibrils and Cardiomyocytes
The protocols used for rapid solution changes and to record force in single myofibrils and cardiomyocytes were as described previously. 18, 19, 21, 22 
Microscopy
To determine whether the cTn complex was homogeneously incorporated into cardiomyocytes, cTn 1-192 -exchanged cardiomyocytes were studied using a Marianas digital imaging microscopy workstation.
Data Analysis
Values are given as meansϮSEM of n myofibrils or myocytes. Differences between preparations with cTn and cTn FL were tested by means of unpaired 2-tailed Student's t tests at a level of significance of 0.05. The effects of sarcomere length and PKA treatment were tested with paired Student's t tests. Figure 1A shows an example of a gel used for the calculation of the amount of exchange in cardiac myofibrils. Replacement of the endogenous troponin complex with cTn amounted to 54Ϯ6% (nϭ4) in human cardiac myofibrils and to 50Ϯ2% (nϭ5) in the isolated human cardiomyocytes. These results confirmed by anti-cTnI Western blot analysis ( Figure 1B for myofibrils and Figure 1C for cardiomyocytes).
Results

Amount and Distribution of Troponin Complex Exchange
To monitor the cTn distribution in cardiomyocytes following the exchange, a novel method was used in which human cardiomyocytes exchanged with cTn were stained with a specific antibody P45-3 and studied using 3D digital imaging microscopy. P45-3 reacts only with full-length cTnI and not with truncated cTnI . Thus, staining with this antibody will reveal any inhomogeneity of cTn exchange into the cardiomyocytes. A summation in the z-axis of the x-y images of a representative cardiomyocyte is shown in Figure 1D . Fluorescence intensity was averaged per xy plane and plotted against plane number in Figure 1E . This panel illustrates that with overnight incubation, the penetration of cTn into the cardiomyocyte is not limited by diffusion, because in that case, a parabolic intensity profile would be expected with a minimum in the core of the preparation. The fluorescence intensity distribution in the y-axis direction ( Figure 1F ) in the central part of the myocyte also reveals a rather homogeneous distribution of cTn complex within the exchanged cardiomyocyte. Three-dimensional image reconstruction performed in 3 typical cTn 1-192 -exchanged cardiomyocytes showed similar results. This indicates that the protocol used ensures a uniform exchange of cTn inside the cardiomyocytes (and in the much thinner myofibrils, where diffusion would be even less critical).
Force Measurements in Exchanged Human Myofibrils
Representative recordings of force production in myofibrils at saturating [Ca 2ϩ ] are shown in Figure 2 . Maximal isometric tension (ie, force at pCa 3.5 divided by cross-sectional area) was not significantly different between cTn FL -and cTn 1-192exchanged myofibrils ( Figure 3A ). However, the rate of tension rise (k ACT ) and the rate of force redevelopment (k TR ) were both significantly decreased in cTn -exchanged myofibrils compared with cTn FL -exchanged myofibrils by 24% and 31%, respectively (PϽ0.05) ( Figure 3B ).
After a rapid switch from activating (pCa 3.5) to relaxing (pCa 9) solution, isometric force started to decline ( Figure 2 ). Force relaxation takes place in 2 phases: a slow initial linear phase, with a rate constant k REL,S calculated from its slope and duration t SLOW ; and a rapid exponential phase characterized by the rate constant k REL,F ( Figure 3C ). 22 The maximum force and kinetic parameters in cTn FL -exchanged myofibrils did not differ significantly from the values obtained in untreated myofibrils. However, compared with cTn FL -exchanged myofibrils, the duration of the slow phase t SLOW was significantly increased in cTn -exchanged myofibrils ( Figure 3D ), whereas k REL,S remained unchanged ( Figure  3C ). The k REL,F significantly decreased in cTn -exchanged myofibrils ( Figure 3C ). An overview of averaged data are presented in Table 1 . Figure 1 . A, One-dimensional SDS-PAGE of suspensions of human myofibrils after the exchange procedure with full-length cTnI (cTnI FL ), degraded (cTnI ), or without exogenous cTn complex (control condition [CTR]). B, Subsequent western immunoblot of a SDS-PAGE gel from human myofibrils using an antibody recognizing the fulllength (cTnI) as well as the truncated (cTnI ) form. C, Western immunoblot of cTnI in exchanged human cardiomyocytes. D, Image obtained by summation of plane intensities along the z-axis of a single cardiomyocyte exchanged with cTn , incubated with an antibody directed against C terminus of cTnI. Scale barϭ10 m. E, Distribution of the fluorescence intensity within the cardiomyocyte. Planes were acquired along the z-axis (in depth) from the top of the myocyte (plane 1) to its bottom (plane 31). F, Distribution of the fluorescence intensity along the vertical (y-axis) of the cardiomyocyte in its central part (planes 11 to 21). MW indicates molecular weight marker.
Force Measurements in Exchanged Human Cardiomyocytes
The maximal isometric tension and its Ca 2ϩ sensitivity could be determined more accurately in cardiomyocytes than in myofibrils, because the cross-sectional area could be determined with a higher precision in cardiomyocytes than in myofibrils ( Figure 4A ). Representative force recordings of cTn FL -and cTn -exchanged myocytes are presented in Figure 4B . Maximal isometric tension and mean passive tension were not significantly different between cTn FL -and cTn -exchanged myofibrils ( Figure 5A ). However, cTn cardiomyocytes had a significantly higher Ca 2ϩ sensitivity than cTn FL -exchanged cardiomyocytes (pCa 50 : 5.79Ϯ0.02 and 5.54Ϯ0.02 for cTn and cTn FL , respectively; PϽ0.05) ( Figure 5B ). Moreover, the cooperativity of force development (nH) was significantly decreased in cTn 1-192 -exchanged cardiomyocytes (1.95Ϯ0.06 and 2.95Ϯ0.14 for cTn and cTn FL , respectively; PϽ0.05).
Sarcomere Length Dependence
To investigate the effect of cTnI proteolysis on the Frank-Starling mechanism, force development and its Ca 2ϩ sensitivity was studied in cardiomyocytes after exchange. Measurements were performed near slack length, at a sarcomere length of 1.9 m and after adjustment of sarcomere length to 2.2 m. As expected on the basis of the sarcomere length/ tension relation, maximum force increased for both cTn FL and cTn cardiomyocytes. Passive tension increased as well. Ca 2ϩ sensitivity also increased with sarcomere length ( Figure   Figure 2 . A, Image of a thin bundle of cTn FL -exchanged human cardiac myofibrils. Length between the attachments 40 m. B, Representative traces of tension activation. C, Relaxation in cTn FL -and cTn -exchanged human cardiac myofibrils. After the myofibril was transferred into activating solution (pCa 3.5) and active force developed, the myofibril was shortened by 20% of its length. Relaxation kinetics were obtained after return of the myofibril into relaxing solution (pCa 8). Maximal tension: k ACT and k TR were obtained at maximal ͓Ca 2ϩ ͔ (pCa 3.5). t SLOW , k REL,S , k REL,F were obtained in relaxing solution (pCa 9). Values are given as meanϮSEM of n myofibrils ( †nϭ21). There were no significant differences between untreated and cTn FL myofibrils. *Significant at PϽ0.05, cTn 1-192 vs cTn FL .
6A), but the steepness of the force/pCa relation (nH) remained the same. The mean shifts in Ca 2ϩ sensitivity (⌬pCa 50 ) were very similar and amounted to 0.10Ϯ0.02 and 0.14Ϯ0.02 for cTn and cTn FL , respectively (Pϭ0.2). An overview of averaged data are presented in Table 2 .
Effects of PKA
To assess the effect of PKA phosphorylation of cTnI and its truncated fragment, cardiomyocytes after cTn exchange were incubated with the catalytic subunit of protein kinase A. Addition of PKA resulted in a decrease in Ca 2ϩ sensitivity and, for cTn cardiomyocytes, in a small but significant increase in steepness of the force/pCa relation ( Figure 6B ). The mean shifts in Ca 2ϩ sensitivity (⌬pCa 50 ) were very similar and amounted to 0.08Ϯ0.01 and 0.09Ϯ0.01 for cTn and cTn FL , respectively (Pϭ0.5). Maximum forces were not influenced by PKA. Mean passive forces were slightly reduced after PKA treatment, but the differences were not significant. An overview of the averaged data are included in Table 2 .
Comparison Between Properties of cTn FL -Exchanged Cardiomyocytes and Untreated Controls
Measurements were also performed in untreated cardiomyocytes from the same donors as used for the exchange experiments. The maximum force in untreated cardiomyocytes 26.9Ϯ3.2 kN/m 2 (nϭ4) did not differ significantly from the value in cTn FL -exchanged cardiomyocytes: 31.5Ϯ3.2 kN/m 2 (nϭ12; Figure 5B ), whereas the pCa 50 values observed were consistent with the observed difference in cTnI phosphorylation (online data supplement), ie, Ca 2ϩ responsiveness was significantly higher in exchanged preparations containing dephosphorylated full-length cTnI (pCa 50 ϭ5.54Ϯ0.02) than in untreated cardiomyocytes (pCa 50 ϭ5.48Ϯ0.01) in which the amount of dephosphorylated cTnI was lower.
Discussion
This study describes the first exchange experiments in human cardiac preparations, in which the direct effects of cTnI degradation are assessed. The results obtained indicate that (1) cTnI degradation at the C terminus enhances myofilament Ca 2ϩ sensitivity and slows force development as well as its relaxation, whereas (2) maximal isometric force development, passive force, length-dependent activation (the Frank-Starling effect), and the responsiveness to ␤-adrenergic stimulation appear to be preserved.
Comparison With Previous Studies on cTnI 1-192 Function
The decrease in maximal force generating capacity of cardiac muscle is among the main features of reversible ischemia/ reperfusion injury (stunning) in rodents and has been attributed to degradation of cTnI, primarily at its C terminus. 7, 8, 23 In a transgenic mouse line expressing 9% to 17% of truncated human cTnI, 1,24 maximal force development of intact trabeculae was approximately 40% depressed compared with nontransgenic mice. In view of these previous findings, it is surprising that in our study, the maximum force was not affected in human preparations containing truncated cTnI. However, it should be noted that the processes involved in stunning differ in small and large animals. 25 The reduction in force in animal models could, at least in part, also be attributable to an additional degradation or modification of other, ultrastructural proteins 15 or to secondary reactive oxy- Figure 4 . A, Images of single cardiomyocytes after exchange with cTn FL and cTn . Scale barϭ20 m. B, Force recordings in cardiomyocytes with cTn FL and cTn at pCa 4.5. During activation, the myocyte was shortened rapidly to determine the baseline of the force transducer. After return into the relaxing solution (pCa 9), the myocyte was shortened again for 10 s to determine passive force. Figure 5 . A, Mean values of maximal isometric force (F max ) and passive force (F pas ) with cTn FL and cTn obtained at saturating [Ca 2ϩ ] (pCa 4.5) and at low [Ca 2ϩ ] (pCa 9), respectively. B, The Ca 2ϩ sensitivity of isometric force with cTn FL and cTn . Isometric force at submaximal activating [Ca 2ϩ ] was normalized to control force at saturating [Ca 2ϩ ]. Ca 2ϩ sensitivity with cTn was significantly higher than with cTn FL . Values are given as mean of 12 cardiomyocytes with cTn FL and 15 with cTn . Error bars indicate SEM.
gen species-related effects. 26 Moreover, other compensatory protein changes, which may develop in transgenic animals, and species differences may be involved as well.
An in vitro motility assay, with reconstituted actin filaments attached to anchoring ␣-actinin, showed a 24% decrease in an index of force development of filaments consisting of 100% human cTnI , compared with filaments with full-length cTnI. 17 This reduction probably would have been less with partial replacement of human cTnI , as was the case in our experiments. Exchange of the human cTn complex into rabbit psoas myofibrils under the same experimental conditions as used in this study, revealed a 26% decrease in maximal force develop-ment in comparison with cTn FL preparations. 27 A similar reduction of maximal tension was observed by Tachampa and coworkers, 28, 29 where the endogenous rat cTn complexes were partly exchanged with truncated human or mice cTn. The main difference in these exchange experiments is that chimerical thin filaments were formed, whereas in the present experiments human cardiac proteins were exchanged into human cardiac tissue. It is conceivable that, despite 95% identity of the human, mice, rat, and rabbit cTn amino acid sequences, signal transduction and transmission between troponin subunits and other contractile proteins is isoform and species dependent. This might result in diverse functional changes on cTnI exchange In both cases, Ca 2ϩ sensitivity at 2.2 m was significantly higher than at 1.9 m. Values are given as mean of 10 cardiomyocytes with cTn FL and 12 with cTn . B, Ca 2ϩ sensitivity of isometric force of cardiomyocytes with cTn FL and with cTn before (open symbols) and after (closed symbols) PKA treatment, determined at a sarcomere length of 2.2 m. Isometric force at submaximal activating [Ca 2ϩ ] was normalized to the control force at saturating [Ca 2ϩ ] (pCa 4.5). In both cases, Ca 2ϩ sensitivity after PKA treatment was significantly reduced. Values are given as mean of 10 cardiomyocytes with cTn FL and 13 with cTn . Error bars indicate SEM. in matching or nonmatching species, but further experiments are required to test this hypothesis.
In viable remote remodeled tissue after infarction in pigs, minor degradation of cTnI (Ͻ4%) was observed, whereas the maximal force-generating capacity was reduced. 9 If our findings in humans are characteristic for the situation in large animal models, this would suggest that other factors than cTnI degradation would be responsible for this loss in force.
The results on kinetics and Ca 2ϩ sensitivity observed in the present study are in line with those found in exchange experiments using rabbit psoas myofibrils and rat cardiac trabeculae. [27] [28] [29] This indicates that the impact of cTnI degradation on regulatory and kinetic aspects of contractile function in rodent and human tissue are shared. However, caution should be exerted with the interpretation of these findings within the context of stunning. For instance Gao and coworkers 30, 31 have observed an increase in k TR and also provided evidence suggesting that the rate-limiting step of the transition from force-generating to non-force-generating states was accelerated in stunned myocardium. Moreover, the direction of the change in the maximum shortening velocity in stunned myocardium is unclear. 32
Structural and Biochemical Considerations on cTnI 1-192 Function
Previous studies indicate that the presence of cTn and TM enhance force development and also influence kinetic parameters of cross-bridge interaction. [33] [34] [35] This suggests that cTnI degradation may affect the maximum force-generating capacity as well as the kinetics of activation and relaxation of force. However, if steric hindrance of cross-bridge interaction by the C-terminal end of cTnI would be important, as suggested previously to explain the increase in ATPase activity, 17 its truncation would tend to increase the number of interacting cross-bridges. This would result in an increase in force rather than in a decrease.
The increase in Ca 2ϩ sensitivity observed can be caused by (1) an increase in Ca 2ϩ affinity of cTnC, which promotes the transition from blocked to closed state; and/or (2) enhancement of strong myosin binding to actin, the transition from closed to open state. 36, 37 It has been shown using various truncated forms of cTnI that progressive deletion of parts of the C terminus impairs the ability of cTnI to bind to actin/tropomyosin at low [Ca 2ϩ ], promoting the availability of actin for binding with myosin. 38 This is consistent with the increase in Ca 2ϩ sensitivity observed in our experiments. The nH of cardiomyocytes exchanged with cTn was significantly lower than that of cTn FL -exchanged cardiomyocytes. This may reflect a decrease in cooperativity of thin filament activation, in agreement with the destabilization of TM on actin, but it could also be caused by the increase in Ca 2ϩ sensitivity because Ca 2ϩ activation of force becomes more dependent on Ca 2ϩ binding to troponin C, which is a relatively noncooperative process.
Both k ACT and k TR of the cTnI -exchanged cardiomyocytes were significantly decreased. Evidence suggests that k ACT and k TR are mainly determined by the kinetics of cross-bridge attachment. 21 The parallel changes in k ACT and k TR observed is these experiments are most likely attributable to cooperative changes within the thin filament that lead to the transition to the open state. Thus, the decreased cooperativity of thin filament regulation may play a role in the slowing of the activation kinetics.
It has been shown that during the first slow linear phase of relaxation, all sarcomeres remain isometric, whereas the fast relaxation phase starts when the first mechanically weakest sarcomere "gives." 22, 39 The slow k REL,S is determined largely by the isoform of myosin heavy chain. 22 This may explain the lack of a significant effect of cTnI degradation on this parameter in our experiments. The duration of the slow phase t SLOW was, however, increased in cTn -exchanged preparations, ie, sarcomeres remain isometric for a longer time during relaxation. This might be a consequence of persistent enhanced activation caused by the increased Ca 2ϩ sensitivity. Moreover, it has been shown that the fast k REL,F depends inversely on the final steady-state force after relaxation. 21 Because cTnI incorporation into myofilaments increases Ca 2ϩ sensitivity, the force during relaxation is larger and accordingly the fast k REL,F will be decreased. Thus, changes in both t SLOW and fast k REL,F may be linked to the increased Ca 2ϩ sensitivity.
In a simple 2-state model for cross-bridge interaction the maximum isometric force is proportional to the number of cross-bridges in the force generating state (N att ), ie, f/(fϩg) and k TR ϭfϩg, where f equals the rate of cross-bridge attachment and g equals the rate of cross-bridge detachment. 21 If we assume that at saturating Ca 2ϩ concentrations gϭk REL,S , N att amounts to 0.6, both for cTn and cTnI FL . Hence, the kinetic values obtained are consistent with the preservation of the maximum force-generating capacity observed.
The reduction in the kinetic parameters cannot be reconciled easily with the increase in ATPase rate observed earlier. 17 However, it should be noted that the ATPase rate reported characterizes the activity during unloaded shortening, whereas our observations characterize the isometric steady state.
Modulation of Contractile Function
Evidence suggests that cTnI, the N-terminal region in particular, is involved in length-dependent activation (the Frank-Starling mechanism). 40 Our results indicate that the sarcomere length dependency of maximum force development and its Ca 2ϩ sensitivity in cTnI 1-192 -containing cardiomyocytes were very similar to those containing full-length cTnI. The location of the putative length sensor, the mechanism underlying the Frank-Starling mechanism as well as the involvement of other proteins such as titin, myosin-binding protein C, and myosin light chain 2 still need to be addressed in human myocardium. However, our data suggest that the C-terminal truncated part of cTnI is not essential for signal transmission of length-dependent activation.
The effects of ␤-adrenergic stimulation were mimicked using PKA. In a previous study, it has been shown that the PKA sites of the endogenous cTnI in donor tissue were almost completely phosphorylated and that cTnT was partially monophosphorylated (Ϸ60%). 41 These endogenous complexes were partly exchanged in our experiments with dephosphorylated cTnI (and cTnT). Consistent with these earlier results, the shift in pCa 50 on PKA treatment was intermediate between the shift observed in donor and endstage failing heart tissue. 41 However, because treatment of both complexes was identical, the overall phosphorylation levels will be the same, as was confirmed by the Western blots shown in the online data supplement. Hence, our experiments revealed that the desensitizing effect of PKA was preserved in cTnI -containing cardiomyocytes. This indicates that the transduction of the PKA-induced phosphorylation signal from cTnI to the regulatory site of cTnC is preserved.
Recently, Metzger and colleagues 42 provided evidence that replacement of alanine with histidine at position 163 in human cTnI may represent a therapeutic avenue to improve myocardial performance in the ischemic and failing heart. Because alanine 163 is within the region retained after cTnI proteolysis and our data show that the regulatory aspects of cTnI are preserved, the engineering of the histidine button may be protective also in the presence of degraded cTnI.
Implications for Cardiac Function In Vivo
The amount of cTn exchange into cardiac preparations in our experiments was approximately 50%, whereas the degree of cTnI degradation observed in failing human myocardium was less (up to 26%). 2 Thus, we expect that the slowing of the kinetics and the increase in Ca 2ϩ sensitivity in failing human myocardium will be less pronounced than observed in our study.
The slowing of relaxation after cTn exchange observed in the present study suggests that cTnI degradation in vivo might impair cardiac relaxation and contribute to diastolic dysfunction, whereas the increased myofilament Ca 2ϩ sensitivity with preserved maximal force generating capacity implies that at low Ca 2ϩ concentrations present during systole, more force will be developed. However in vivo, during a twitch, this effect will be counteracted by the slowing of force development in preparations with cTn . The net effect during systole might thus be rather small. Hence, our data indicate that diastolic dysfunction in ischemic and failing human myocardium 43, 44 might, at least in part, be attributable to cTnI proteolysis.
